A Future for Pharma: Modern Management from Studies to Submissions
Instem Team
This presentation discusses next-generation study management solutions designed to solve industry challenges highlighted by our collaborators and users.
Regulatory Submission Blog
Application Areas
Clinical Stage
Product
Reusing SEND Data for ICH S1B Submissions: Faster, Cost-Effective Carcinogenicity Assessments
In this article, we explore how SEND data can be used in data gathering for WoE submissions and the key time and cost benefits for sponsors looking to streamline their submissions.
Live SEND Webinar featuring Instem’s Marc Ellison
Instem Team
The Past, Present, and Future of SEND: The Continuing Evolution of Our Nonclinical Standard
SENDIG-GeneTox v1.0: What You Need to Know
Instem Team
Preparing your regulatory team for the new SENDIG-GeneTox requirements.
What changes can we expect for the SEND world in 2025?
Marc Ellison
Read the latest from our Sensible SEND blog.
Sensible SEND – Supporting Smart People with Smart Science
Marc Ellison
Read the latest blog from Marc Ellison, Director, SEND Solutions, Instem.
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.
